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Abstract Matrix metalloproteinase (MMPs) enzymes are
implicated in matrix remodelling during proliferative inflamma-
tory processes including wound healing. We report here
synergistic upregulation of MMP-9 protein and mRNA by
platelet-derived growth factor (PDGF) or basic fibroblast growth
factor (bFGF) in combination with interleukin-1K (IL-1K) or
tumour necrosis factor-K (TNF-K) in primary rabbit and human
dermal fibroblasts. The synergistic interaction between growth
factors and cytokines implies that basement membrane remodel-
ling is maximal physiologically when both are present together.
The signalling pathways mediating this synergistic regulation are
not understood, although analysis of the MMP-9 promoter has
identified an essential proximal AP-1 element and an upstream
nuclear factor kappa-B (NF-UB) site. Using electromobility shift
assays, binding to the AP-1 site was only slightly increased by
growth factors and cytokines. NF-UB binding was rapidly
induced by IL-1K or TNF-K but was neither induced nor
potentiated by bFGF or PDGF. Neither AP-1 nor NF-UB was
therefore sufficient on its own for synergistic regulation. Using a
recently developed adenovirus that overexpresses the inhibitory
subunit, IUBK, we demonstrated an absolute requirement for NF-
UB in upregulation of MMP-9. Activation of NF-UB binding by
inflammatory cytokines was therefore necessary but not
sufficient for synergistic upregulation of MMP-9.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Basement membrane (BM) components perform both struc-
tural and regulatory functions in the proliferation and migra-
tion of connective tissue cells. The matrix degrading metal-
loproteinases (MMPs) are a family of structurally related
enzymes that are capable of promoting physiological turnover
of all extracellular matrix components, for example during
wound healing. Deregulated degradation of BM has also
been implicated in several pathologies including glomerular
nephritis, atherosclerosis and tumour cell invasion [1]. Of
the MMPs, the gelatinase subgroup, comprised of gelati-
nase-A (MMP-2) and gelatinase-B (MMP-9), e⁄ciently de-
grade BM components laminin and type-IV collagen. MMP-
2 is constitutively expressed by many cell types and thought to
be regulated at the level of pro-enzyme activation [2^4].
MMP-9 is transcriptionally regulated by in£ammatory cyto-
kines (tumour necrosis factor-K (TNF-K), interleukin-1K (IL-
1K)) [1,3,5^7]. Few studies have examined the interaction of
connective tissue mitogens (e.g. platelet-derived growth factor
(PDGF), basic ¢broblast growth factor (bFGF) and EGF)
and in£ammatory cytokines, despite the fact that both are
present together in healing wounds. MMP-9 expression in
rabbit aortic smooth muscle cells is una¡ected by PDGF on
its own, submaximally increased by IL-1K alone, but syner-
gistically upregulated by combinations of PDGF and IL-1K
[3]. We sought here to determine whether this synergy applied
to other combinations of growth factors and cytokines, and to
dermal ¢broblasts. We also investigated the molecular mech-
anisms underlying this synergistic regulation.
Several studies have highlighted the absolute requirement
for a conserved proximal AP-1 binding site in the induction
of MMP-9 [7^10]. A distal stimulatory region encompassing
an NF-UB element and an additional AP-1 binding site [7,9]
has also been identi¢ed although it is uncertain whether this is
also essential or merely cooperates with the proximal AP-1
site. We used electromobility shift assays and adenoviral
mediated overexpression of IUBK, the endogenous inhibitor
of NF-UB, to determine the importance of NF-UB in upregu-
lation of MMP-9.
2. Materials and methods
2.1. Materials
Phorbol 12-myristate 13-acetate (PMA) was obtained from Sigma,
Poole, Dorset, UK. Human recombinant platelet-derived growth fac-
tor BB (PDGF BB) and basic ¢broblast growth factor (bFGF) were
purchased from Boehringer Mannheim, Lewes, East Sussex, UK. Hu-
man recombinant interleukin-1K (IL-1K) was a generous gift from
Roche, Welwyn Garden City, Herts, UK. Tumour-necrosis factor-K
(TNF-K) was purchased from RpD Systems, Abingdon, UK. Re-
combinant adenovirus capable of overexpressing porcine IUBK was
a kind gift from Dr Rainer De Martin (Department of Vascular
Biology and Thrombosis Research, University of Vienna, Austria).
Recombinant adenovirus capable of overexpressing the bacterial
LacZ gene [11] and a control virus with a silent expression cassette
were kind gifts form Dr G. Wilkinson (Dept. Cardiology and Medi-
cine, University of Wales College of Medicine, Heath Park, Cardi¡,
UK). Antibody to NF-UB/p65 subunit was obtained from Santa Cruz
Biotechnology, Delaware Avenue, CA, USA.
2.2. Methods
2.2.1. Cell culture. Primary cultures of human foreskin ¢broblasts
and rabbit dermal ¢broblasts were each prepared by modi¢cations of
the explant technique, as previously described in detail [12]. Cells
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between passage one to three were plated at a density of 7U104 cells/
well into 12-well culture plates for zymography and Western blotting
or 8U105 cells/75 cm2 £ask for RNA studies. For all experiments,
subcon£uent cells were rendered quiescent by incubation in serum-free
DMEM supplemented with 0.25% (v/v) lactalbumin hydrolysate (Gib-
co-BRL, Paisley, UK) for 3 days. Cultures were then exposed to fresh
serum-free medium containing the appropriate concentration of the
agent under investigation for varying time intervals.
2.2.2. Zymography. Zymography was used for semi-quantitative
analysis of gelatinase levels secreted into the culture medium as pre-
viously described [3,12]. Human ¢broblasts conditioned media were
concentrated 30-fold by ultra¢ltration (Centricon 30, Amicon, Stone-
house, Gloucestershire, UK) prior to analysis. Gelatinolytic bands
were size calibrated with a high molecular weight standard mixture
of proteins (Sigma). Brie£y, zymograms were loaded so as to yield
bands of lysis that were in the linear range of measurement. Band
intensities were quanti¢ed using a Bio-Rad GS 690 Image Analysis
software system (Bio-Rad Laboratories, Hemel Hempstead, Hertford-
shire, UK) and related to that of a standard mixture of MMP-2 and
-9 run on each zymogram.
2.2.3. Northern analysis. The generation of the MMP-9 and
GAPDH riboprobes has been described previously [3]. Total cellular
RNA was prepared from 1U106 rabbit skin ¢broblast cultures using
Qiagen RNeasy total RNA extraction columns (Hybaid, Teddington,
Middlesex, UK) according to the manufacturer’s instructions. 10 Wg
of RNA was fractionated on 1% agarose/2.2 M formaldehyde gels and
transferred onto Hybond-N membranes (Amersham International) by
capillary blotting overnight using 20U SSC (3 M sodium chloride,
300 mM sodium citrate). RNA integrity and equality of loading was
assessed by staining with 0.03% methylene blue in 0.3 M sodium
acetate, pH 5.2.
Speci¢cally hybridised DIG-labelled probe was detected using the
DIG-detection system (Boehringer Mannheim). Bands were quanti¢ed
using a Bio-Rad GS 690 Image Analysis software system.
2.2.4. Nuclear extracts and electromobility shift assay. Nuclear
proteins were extracted from approximately 1U106 rabbit dermal
¢broblast nuclei as previously described [13]. Binding reactions (20
Wl) containing 2 Wg poly(dI-dC), 10 mM HEPES, pH 7.9, 50 mM
NaCl, 0.5 DDT, 2.5 mM EDTA, 7 mM MgCl2, 4% glycerol, and
4^6 Wg nuclear extract were incubated on ice for 30 min with 20 000
cpm of 32P-labelled oligonucleotide corresponding to the rabbit
MMP-9 NF-UB element (5P-..CCC CGG TGG AAT TCC CCA
AAT CCT..-3P) or the proximal AP-1 element (5P-..CCG GCC CTG
AGT CAG CAC TTG CCT G..-3P). Complexes were separated on 6%
non-denaturing polyacrylamide gels.
3. Results
3.1. Combinations of cytokines and growth factors
synergistically stimulate MMP-9 expression
As shown by zymography in Fig. 1, IL-1K but not TNF-K
alone gave a barely detectable stimulation of MMP-9 secre-
tion. PDGF or bFGF alone did not increase MMP-9 secre-
tion. Combinations of IL-1K (Fig. 1B) or TNF-K (Fig. 1A)
with PDGF acted synergistically and even greater e¡ects were
seen with combinations of bFGF with either IL-1K or TNF-K.
TNF-K was consistently less e¡ective than IL-1K. Combina-
tions of PDGF and bFGF were ine¡ective in stimulating
MMP-9 secretion, while combinations of IL-1K and TNF-K
were at best additive (results not shown). MMP-9 secretion
from human foreskin ¢broblasts was also synergistically upre-
gulated by PDGF or bFGF plus IL-1K (data not shown). In
human cells, the e¡ect of bFGF plus IL-1K was similar to that
of PDGF plus IL-1K. No changes in MMP-2 levels were seen
in either cell type under any of the conditions tested (Fig.
1A,B, and not shown).
Northern blotting (Fig. 2) showed that MMP-9 mRNA
levels were also upregulated by combinations of PDGF or
bFGF plus IL-1K, as early as 4 h after stimulation. bFGF
was more e¡ective than PDGF, consistent with the protein
secretion data.
3.2. Role of AP-1 and NF-UB transcription factors in MMP-9
upregulation
Electromobility shift assays (EMSA) demonstrated high
basal levels of AP-1 binding that were only slightly increased
by IL-1K, bFGF or their combination with no evidence of
synergy (Fig. 3B). EMSA demonstrated strong and rapid
NF-UB activation in response to IL-1K but not bFGF stim-
ulation (Fig. 3A). bFGF did not enhance the binding in re-
sponse to IL-1K. These results were con¢rmed by immuno-
£uorescent staining using a p65 speci¢c antibody (results not
shown). Strong NF-UB nuclear translocation occurred in re-
sponse to a 45-min stimulation with IL-1K or TNF-K ; PDGF
and bFGF neither stimulated nor enhanced NF-UB nuclear
translocation. These results established that neither AP-1 nor
NF-UB binding alone was su⁄cient to explain MMP-9 regu-
lation.
To establish whether NF-UB activity was necessary or not
for synergistic regulation of MMP-9, we employed a recombi-
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Fig. 1. E¡ect of IL-1K, TNF-K, bFGF and PDGF-BB on MMP-9
secretion. Conditioned media from quiescent rabbit dermal ¢bro-
blasts incubated for 16 h without serum. A: With combinations of
TNF-K with PDGF or bFGF. Lane 1: control; lane 2: 10 ng/ml
TNF-K ; lane 3: 20 ng/ml PDGF-BB; lane 4: TNF-K+PDGF; lane
5: 20 ng/ml bFGF; lane 6: bFGF+TNF-K. B: With combinations
of IL-1K with PDGF or bFGF. Lane 1: control; lane 2: 10 ng/ml
IL-1K ; lane 3: 20 ng/ml PDGF-BB; lane 4: IL-1K+PDGF; lane 5:
20 ng/ml bFGF; lane 6: bFGF+IL-1K was subjected to gelatin zy-
mography and densitometric analysis. Values are means þ S.E.M. of
3 separate experiments.
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nant adenovirus (RAd:IUBK) [14] to overexpress IUBK, the
NF-UB inhibitory subunit. Using Rad35:Lgal [11], a recombi-
nant adenovirus that expressed the bacterial LacZ gene, dem-
onstrated that a multiplicity of infection (MOI) of 250 pfu/ml
was required to achieve a 100% infection e⁄ciency (data not
shown). Similar infection with RAd:IUBK but not RAd66:
null virus increased expression of IUBK measured by Western
blotting (not shown). RAd:IUBK but not RAd66:null com-
pletely inhibited IL-1K induced NF-UB DNA binding activity
(Fig. 4A), which was further identi¢ed by antibody supershift
(Fig. 4B). As a proof of speci¢city, RAd:IUBK was shown not
to a¡ect AP-1 DNA binding (Fig. 4C), cell viability or serum
induced proliferation (data not shown). Infection with RAd:
IUBK but not RAd66:null completely inhibited MMP-9 secre-
tion (Fig. 5A) and steady state mRNA expression (Fig. 5B) in
response to all agonists tested, alone or in combination. The
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Fig. 2. Synergistic regulation of MMP-9 steady state mRNA expression. Total RNA from quiescent rabbit dermal ¢broblasts incubated for 4 or
8 h without serum with: lane 1: unstimulated control; lane 2: 10 ng/ml IL-1K ; lane 3: 20 ng/ml PDGF-BB; lane 4: IL-1K+PDGF-BB; lane 5:
20 ng/ml bFGF; lane 6: IL-1K+bFGF; lane 7: 1037 M PMA was analysed for steady state MMP-9 (panel A) and GAPDH (panel B). Blots
were analysed by densitometry and normalised as a percentage of the response to IL-1K plus bFGF after 8 h. Values are mean þ S.E.M. for
3 separate experiments.
Fig. 3. Activation of NF-UB and AP-1 DNA binding by cytokines and growth factors. Nuclear extracts were prepared from quiescent rabbit
dermal ¢broblasts after 3-h stimulation with 10 ng/ml IL-1K, 20 ng/ml bFGF or 1037 M PMA. Lane 1: control; lane 2: IL-1K ; lane 3:
bFGF; lane 4: IL-1K+bFGF; lane 5: PMA. Nuclear extracts were analysed for (A) NF-UB DNA binding activity and (B) AP-1 binding activ-
ity by EMSA (protein/DNA complexes indicated by arrows). Binding speci¢city was demonstrated with addition of 200-fold excess of unla-
belled speci¢c or irrelevant oligonucleotide to binding reactions containing IL-1K induced nuclear extracts. A: Lane 6: excess AP-1 oligonucleo-
tide; lane 7: excess NF-UB oligonucleotide; B: lane 6: excess NF-UB oligonucleotide; lane 7: excess AP-1 oligonucleotide.
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constitutive secretion of MMP-2 and the steady state mRNA
expression of the GAPDH, genes that lack NF-UB regulatory
elements, were una¡ected.
4. Discussion
We have demonstrated that the synergistic upregulation of
MMP-9 secretion is not restricted to PDGF and IL-1K in
smooth muscle cells [3] but is an example of a more general
regulatory mechanism of potential physiological importance.
IL-1K or TNF-K interacted synergistically with either PDGF
or bFGF. Synergistic regulation occurs also at the mRNA
level at early time points. This regulatory mechanism is com-
mon to both rabbit and human ¢broblasts. Activation of AP-
1 and NF-UB transcription factors is insu⁄cient but abso-
lutely required for upregulation of MMP-9.
Increased expression of gelatinase-B occurs in response to
IL-1K and TNF-K in a number of cell types [1,5,15]. IL-1K
and TNF-K are secreted by activated macrophages, leukocytes
and connective tissue cells [16^18], with increased levels of
these factors associated with several degradative in£ammatory
diseases and healing wounds [19,20]. The data presented here
illustrate an additional requirement for growth factor stimu-
lation to achieve maximal MMP-9 secretion. Several studies
have reported increased levels of connective tissue mitogens
such as PDGF and bFGF at sites of tissue damage and in-
£ammation [17,21]. Activation of macrophages and cell injury
can both result in release of bFGF and PDGF [17,22^24]. The
synergistic pattern of MMP-9 upregulation reported here is
therefore likely to be of physiological importance.
Synergistic interactions between growth factors and cyto-
kines mediating various biological responses have been re-
ported previously. Bonin et al. [25] reported that IL-1 enhan-
ces the growth promoting activity of PDGF and macrophage
derived growth factor (MDGF). However, IL-1 induced pro-
liferation of ¢broblasts and smooth muscle cells has been
reported to be due to induction and release of PDGF-AA,
suggesting that this synergy may be due to initiation of auto-
crine or paracrine stimulation [26]. Chandrasekhar et al.
[27,28] reported cooperative e¡ects of IL-1 and bFGF on
metalloproteinase gene expression in rabbit articular chondro-
cytes which may be due to increased numbers of IL-1 recep-
tors. However, stimulation with 100 ng/ml bFGF (5-fold the
concentration used here) only resulted in a doubling of IL-1
receptor numbers, while greatly enhancing MMP secretion,
which implies the involvement of additional mechanisms
such as those de¢ned here [27]. Increase in IL-1 receptors
and ensuing signal transduction cannot account for the in-
crease in MMP-9 expression seen in this study. Firstly, the
e¡ect on MMP-9 mRNA expression occurred within 4 h, in-
su⁄cient time for increased receptor expression. Secondly, we
demonstrated that NF-UB activation, an early event down-
stream of cytokine receptor occupation, was not potentiated
by addition of growth factor (Fig. 3). Finally, we have found
that induction of another cytokine induced gene, VCAM-1, is
not at all potentiated by PDGF or bFGF stimulation (M.
Bond and A.C. Newby, unpublished observations). Taken to-
gether, these data imply that the synergistic interactions be-
tween cytokines and growth factors reported most probably
results from activation of multiple interacting signal transduc-
tion pathways.
PDGF and bFGF typically activate the ERK-1/ERK2
MAP kinase pathway, leading ultimately to activation of
AP-1 transcription factors. TNF-K and IL-1K activate recep-
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Fig. 4. E¡ect of IUBK overexpression on NF-UB and AP-1 DNA binding. Quiescent rabbit dermal ¢broblasts were infected with 250 MOI of
RAd66 control virus or RAd:IUBK virus and stimulated with 10 ng/ml IL-1K or 1037 M PMA as indicated for 3 h, 3 days post infection. A:
Nuclear extracts (approx. 5 Wg) were analysed for NF-UB activity. Lane 1: uninfected, unstimulated control, IL-1K stimulated uninfected cells;
lane 3: IL-1K stimulated RAd66:null control virus infected cells; lane 4: IL-1K stimulated RAd:IUBK infected cells. B: Binding activity was
identi¢ed as NF-UB in IL-1K induced extracts by antibody supershift. Lane 1: control; lane 2: non-immune goat IgG; lane 3: anti-NF-UB/p65.
C: E¡ect of viral infection on PMA induced AP-1 DNA binding. Lane 1: uninfected control; lane 2: RAd66 control virus infected; lane 3:
RAd:IUBK virus infected. Binding speci¢city was con¢rmed with addition of 200-fold excess cold oligonucleotide. Lane 4: 200-fold excess NF-
UB oligonucleotide; lane 5: 200-fold excess AP-1 oligonucleotide. The results are representative of 3 separate experiments.
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tor tyrosine kinase independent pathways, leading to the rapid
activation of NF-UB. From previous studies, the AP-1 tran-
scription factor is known to be essential for MMP-9 expres-
sion in ¢broblasts [7,9]. However, we showed here that in
rabbit dermal ¢broblasts AP-1 DNA binding is poorly regu-
lated by cytokine and growth factor combinations implying
that activation of AP-1 binding alone is insu⁄cient for syner-
gistic upregulation of gelatinase-B. This suggests the interac-
tion with additional factors, of which NF-UB is an attractive
possibility because a functional NF-UB binding element exists
in the gelatinase-B promoter in a region that cooperates with
the proximal AP-1 element [7,9]. Moreover, stable expression
of a dominant negative NF-UB/p65 mutant partially inhibited
IL-1L induced MMP-9 expression in mesangial cells [10]. In
this study, cytokine stimulation of rabbit dermal ¢broblasts
resulted in a rapid and potent activation of NF-UB but little
or no induction of MMP-9 expression. This implied either
that NF-UB activity was unnecessary or insu⁄cient on its
own for full upregulation of the gene. To investigate whether
NF-UB activation was essential for MMP-9 expression, we
used a recombinant adenovirus that overexpresses IUBK, the
endogenous inhibitor of NF-UB. Overexpression of IUBK
completely inhibited NF-UB binding and both MMP-9 protein
and mRNA expression, demonstrating an absolute require-
ment for NF-UB activity in upregulating MMP-9.
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